Category Archives for "News"

Abattis Bioceuticals Comments on BCSC Temporary Order

Abattis Bioceuticals Comments on BCSC Temporary Order November 27, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 27, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) comments on the news release regarding the British Columbia Securities Commission (“BCSC”) Temporary Order dated November 26, 2018. The BCSC issued a temporary […]

Read More

Abattis Bioceuticals Celebrates Release of Comfort through Vergence Naturals

ABATTIS BIOCEUTICALS CELEBRATES RELEASE OF COMFORT THROUGH VERGENCE NATURALS October 11, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 26, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the release of its first proprietary product, Comfort, through the Company’s wholly-owned subsidiary Vergence Naturals (“Vergence”). Comfort, a brand-new proprietary […]

Read More

Abattis Bioceuticals Signs National Distribution Agreement with Shefield & Sons

Abattis Bioceuticals Signs National Distribution Agreement with Shefield & Sons November 27, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 27, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the Company has signed a Distribution Agreement (the “Distribution Agreement”) with Shefield & Sons Tobacconists […]

Read More

Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank

Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank November 23, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 23, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) to acquire 100% of Select Strains Inc. (“Select Strains”). […]

Read More

Abattis Bioceuticals Retains Canadian and American Compliance Agency and Provides Company Update

Abattis Retains Canadian and American Compliance Agency and Provides Company Update November 20, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 20, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the appointment of Ingredient Identity LLC (“Ingredient Identity”), a Canadian and US regulatory and compliance agency, to assist […]

Read More

Abattis Bioceuticals Celebrates Legalization

Abattis Bioceuticals Celebrates Legalization October 17, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / [October 17, 2018] / Abattis Bioceuticals Corp (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) is pleased to celebrate the legalization of cannabis in Canada. This is a truly a newsworthy day in Canadian history, as we formally recognize the end […]

Read More